SCN5A基因突变相关Brugada综合征行S-ICD治疗1例并文献复习
SCN5A Mutation-Related Brugada Syndrome Treated with S-ICD: A Case Report and Literature Review
摘要: Brugada综合征(Brugada syndrome, BrS)是一种常染色体显性遗传的离子通道病,其临床表现多样,以心电图右胸导联特征性ST段抬高和恶性室性心律失常高发风险为特点,在临床中易被漏诊或误诊。现报道1例SCN5A基因突变相关的BrS罕见病例,患者为35岁男性,因发作性心慌1年、加重2个月入院,心电图显示V1、V2导联穹隆型ST段抬高伴T波倒置,符合BrS I型心电图改变。患者祖父39岁猝死,父亲确诊BrS并已植入ICD。基因检测证实患者携带SCN5A c.1066G>A p. (Asp356Asn)杂合致病突变,其女儿未携带该突变。患者成功接受全皮下植入型心律转复除颤器(S-ICD)治疗,术后恢复良好。本例体现了BrS的家族聚集性、遗传异质性及不完全外显特点。
Abstract: Brugada syndrome (BrS) is an autosomal dominant inherited channelopathy characterized by diverse clinical manifestations, distinctive ST-segment elevation in the right precordial leads on electrocardiogram, and a high risk of malignant ventricular arrhythmias. It is prone to missed diagnosis or misdiagnosis in clinical practice. This article reports a rare case of BrS associated with SCN5A gene mutation. A 35-year-old male patient was admitted due to paroxyspal palpitations for one year, worsening over the past two months. Electrocardiography revealed coved-type ST-segment elevation in leads V1 and V2 accompanied by T-wave inversion, consistent with type I BrS electrocardiographic pattern. The patient’s grandfather died suddenly at age 39, and his father was diagnosed with BrS and underwent ICD implantation. Genetic testing confirmed that the patient carried the heterozygous pathogenic SCN5A c.1066G>A p. (Asp356Asn) mutation, which was absent in his daughter. The patient successfully underwent subcutaneous implantable cardioverter-defibrillator (S-ICD) implantation and recovered well postoperatively. This case demonstrates the familial aggregation, genetic heterogeneity, and incomplete penetrance characteristics of BrS.
文章引用:王闻卓, 赵青, 纪阳, 蔡尚郎. SCN5A基因突变相关Brugada综合征行S-ICD治疗1例并文献复习[J]. 临床医学进展, 2026, 16(4): 1964-1971. https://doi.org/10.12677/acm.2026.1641439

参考文献

[1] 简易, 李耀东. Brugada综合征诊断、遗传学及危险分层的研究进展[J]. 心血管病学进展, 2024, 45(6): 519-524.
[2] 王小挺, 王腾美, 柯雯. Brugada综合征合并心室电风暴1例的急救与护理[J]. 中国乡村医药, 2025, 32(22): 47-48.
[3] Kapplinger, J.D., Tester, D.J., Alders, M., Benito, B., Berthet, M., Brugada, J., et al. (2010) An International Compendium of Mutations in the SCN5A-Encoded Cardiac Sodium Channel in Patients Referred for Brugada Syndrome Genetic Testing. Heart Rhythm, 7, 33-46. [Google Scholar] [CrossRef] [PubMed]
[4] Makiyama, T., Akao, M., Tsuji, K., Doi, T., Ohno, S., Takenaka, K., et al. (2005) High Risk for Bradyarrhythmic Complications in Patients with Brugada Syndrome Caused by Scn5agene Mutations. Journal of the American College of Cardiology, 46, 2100-2106. [Google Scholar] [CrossRef] [PubMed]
[5] Milanesi, R., Bucchi, A. and Baruscotti, M. (2015) The Genetic Basis for Inherited Forms of Sinoatrial Dysfunction and Atrioventricular Node Dysfunction. Journal of Interventional Cardiac Electrophysiology, 43, 121-134. [Google Scholar] [CrossRef] [PubMed]
[6] Shinlapawittayatorn, K., Dudash, L.A., Du, X.X., Heller, L., Poelzing, S., Ficker, E., et al. (2011) A Novel Strategy Using Cardiac Sodium Channel Polymorphic Fragments to Rescue Trafficking-Deficient scn5a Mutations. Circulation: Cardiovascular Genetics, 4, 500-509. [Google Scholar] [CrossRef] [PubMed]
[7] Rojas, R., Kaul, R., Frenkel, D., Hoch, E.G., Iwai, S., Jacobson, J.T., et al. (2021) Brugada Syndrome Clinical Update. Hospital Practice, 49, 255-261. [Google Scholar] [CrossRef] [PubMed]
[8] Kumar, A., Tantray, J., Kosey, S., Devi, C.H. and Prajapati, B. (2025) Decoding Brugada Syndrome: A Comprehensive Analysis of Pathophysiology, Genetic Foundations and Advanced Clinical Management. Health Sciences Review, 16, Article 100238. [Google Scholar] [CrossRef
[9] Vutthikraivit, W., Rattanawong, P., Putthapiban, P., et al. (2018) Worldwide Prevalence of Brugada Syndrome: A Systematic Review and Meta-Analysis. Acta Cardiologica Sinica, 34, 267-277.
[10] Moras, E., Gandhi, K., Narasimhan, B., Brugada, R., Brugada, J., Brugada, P., et al. (2023) Genetic and Molecular Mechanisms in Brugada Syndrome. Cells, 12, Article 1791. [Google Scholar] [CrossRef] [PubMed]
[11] 袁梦. 两名临床疑似Brugada综合征患者的致病基因及变异鉴定[D]: [硕士学位论文]. 长沙: 中南大学, 2022.
[12] Liantonio, A., Bertini, M., Mele, A., Balla, C., Dinoi, G., Selvatici, R., et al. (2023) Brugada Syndrome: More than a Monogenic Channelopathy. Biomedicines, 11, Article 2297. [Google Scholar] [CrossRef] [PubMed]
[13] Giudicessi, J.R. and Ackerman, M.J. (2013) Determinants of Incomplete Penetrance and Variable Expressivity in Heritable Cardiac Arrhythmia Syndromes. Translational Research, 161, 1-14. [Google Scholar] [CrossRef] [PubMed]
[14] Deliniere, A., Bessiere, F., Moreau, A., Janin, A., Millat, G. and Chevalier, P. (2018) Brugada Type 1 Pattern and Risk Stratification for Sudden Death: Does the Key Hide in the ECG Analysis? In: Lakshmanadoss, U., Ed., Cardiac Arrhythmias, InTech. [Google Scholar] [CrossRef
[15] Moscoso, I., Serrano-Cruz, V., Cebro-Márquez, M., Vilar-Sánchez, M.E., Vidal-Abeijón, I., Brion, M., et al. (2025) Epigenetic Regulation of Electromechanical Continuity Might Determine Phenotypic Heterogeneity in SCN5A Mutation Carriers in Brugada Syndrome. Scientific Reports, 15, Article No. 36885. [Google Scholar] [CrossRef
[16] Scarà, A., Sciarra, L., Russo, A.D., Cavarretta, E., Palamà, Z., Zorzi, A., et al. (2025) Brugada Syndrome in Sports Cardiology: An Expert Opinion Statement of the Italian Society of Sports Cardiology (SICSport). The American Journal of Cardiology, 244, 9-17. [Google Scholar] [CrossRef] [PubMed]
[17] Kan, K.Y., Van Wyk, A., Paterson, T., Ninan, N., Lysyganicz, P., Tyagi, I., et al. (2025) Beyond the Type 1 Pattern: Comprehensive Risk Stratification in Brugada Syndrome. Journal of Interventional Cardiac Electrophysiology, 68, 1771-1790. [Google Scholar] [CrossRef] [PubMed]
[18] Rattanawong, P. and Shen, W. (2026) Brugada Syndrome Risk Scores: What We’ve Learned and What’s Next. Frontiers in Cardiovascular Medicine, 12, Article ID: 1715146. [Google Scholar] [CrossRef
[19] Shinohara, T., Takagi, M., Kamakura, T., Sekiguchi, Y., Yokoyama, Y., Aihara, N., et al. (2021) Risk Stratification in Asymptomatic Patients with Brugada Syndrome: Utility of Multiple Risk Factor Combination Rather than Programmed Electrical Stimulation. Journal of Cardiovascular Electrophysiology, 32, 507-514. [Google Scholar] [CrossRef] [PubMed]
[20] Zumhagen, S., Stallmeyer, B., Eckardt, L. and Schulze-Bahr, E. (2017) (Tpeak-Tend)/QRS and (Tpeak-Tend)/(QT × QRS) as Risk Markers in Brugada Syndrome: Authors’ Reply. EP Europace, 19, 696-697. [Google Scholar] [CrossRef] [PubMed]
[21] O’Neill, M.J., Ma, J.G., Aldridge, J.L., Solus, J.F., Harvey, G.R., Roberson, P.H., et al. (2025) Automated Patch Clamp Data Improve Variant Classification and Penetrance Stratification for SCN5A—Brugada Syndrome. European Heart Journal, 18, ehaf874. [Google Scholar] [CrossRef
[22] Russo, V., Caturano, A., Guerra, F., Migliore, F., Mascia, G., Rossi, A., et al. (2023) Correction to: Subcutaneous versus Transvenous Implantable Cardioverter-Defibrillator among Drug-Induced Type-1 ECG Pattern Brugada Syndrome: A Propensity Score Matching Analysis from IBRYD Study. Heart and Vessels, 38, 689-690. [Google Scholar] [CrossRef] [PubMed]
[23] Hennessey, J.A. and El-Chami, M.F. (2026) Brugada Syndrome Treatment & Management. Medscape.
[24] Melnychuk, V., Saxena, S., Ergle, K. and El Sabbagh, F. (2025) Incessant Electrical Storm in a Patient with Brugada Syndrome Provoked by Previously Unreported Syndrome-Inducing Medication. JACC: Case Reports, 30, Article 105014. [Google Scholar] [CrossRef] [PubMed]
[25] Ballacci, F., Giordano, F., Scacciavillani, R., Vetta, G., Pannone, L., Della Rocca, D.G., et al. (2025) Catheter Ablation to Prevent Malignant Ventricular Arrhythmias in Symptomatic Brugada Syndrome: A Systematic Review and Meta-Analysis. Heart Rhythm, 22, 3328-3336. [Google Scholar] [CrossRef